Dr. Jamilur Reja, Internal Medicine Medicare: Medicare Enrolled Practice Location: 275 South St, Oyster Bay, NY 11771 Phone: 516-676-0239 |
Dr. John A Reyes, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15a Berry Hill Rd, Oyster Bay, NY 11771 Phone: 516-671-6900 Fax: 516-671-6901 |
Dr. Stephen Hom, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 W Main St, Oyster Bay, NY 11771 Phone: 516-922-1151 |
Dr. Robert Feldman Slifkin, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1234 The Knl, Oyster Bay, NY 11771 Phone: 516-626-8947 Fax: 516-626-0496 |
Shirley R Andersen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 180 South St, Oyster Bay, NY 11771 Phone: 516-922-5188 Fax: 516-922-6554 |
Dr. Julia Yvonne Oweis, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 22 Creek Ln, Oyster Bay, NY 11771 Phone: 516-778-0022 Fax: 516-226-1871 |
Dr. Glenford Delacy Nixon, MD Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 8 South Rd, Oyster Bay, NY 11771 Phone: 516-922-1056 |
Radha T Krishnan, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 52 Woodland Dr, Oyster Bay, NY 11771 Phone: 516-922-7521 Fax: 516-624-8210 |
News Archive
In a pair of firsts, researchers at Case Western Reserve University and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more effective than an approved drug in vivo, and that a plant-virus-based carrier successfully delivers a drug in vivo.
In their recent paper released on the bioRxiv preprint server, a research group from Spain demonstrated how genome changes and deletions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could represent a strategy of natural selection used for lessening the impact of infection in order to increase viral transmission potential.
Sodexo's (PARIS:SW) (OTCBB:SDXAY) Board of Directors met on November 6, 2009 under the chairmanship of Pierre Bellon to close the accounts for the year ended August 31, 2009. Michel Landel, Chief Executive Officer, presented the financial results for Fiscal 2009.
Electronic cigarettes, or e-cigs, have grown in popularity as an alternative to traditional cigarette smoking.
› Verified 1 days ago